Cargando…
Helicobacter pylori treatment in the post-antibiotics era—searching for new drug targets
ABSTRACT: Helicobacter pylori, a member of Epsilonproteobacteria, is a Gram-negative microaerophilic bacterium that colonizes gastric mucosa of about 50% of the human population. Although most infections caused by H. pylori are asymptomatic, the microorganism is strongly associated with serious dise...
Autores principales: | Roszczenko-Jasińska, Paula, Wojtyś, Marta Ilona, Jagusztyn-Krynicka, Elżbieta K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666284/ https://www.ncbi.nlm.nih.gov/pubmed/33052519 http://dx.doi.org/10.1007/s00253-020-10945-w |
Ejemplares similares
-
A Novel Insight into the Oxidoreductase Activity of Helicobacter pylori HP0231 Protein
por: Roszczenko, Paula, et al.
Publicado: (2012) -
Correction: A Novel Insight into the Oxidoreductase Activity of Helicobacter pylori HP0231 Protein
por: Roszczenko, Paula, et al.
Publicado: (2012) -
Helicobacter pylori in the post-antibiotics era: from virulence factors to new drug targets and therapeutic agents
por: Al-Fakhrany, Omnia Momtaz, et al.
Publicado: (2023) -
Interactions of 2,6-substituted purines with purine nucleoside phosphorylase from Helicobacter pylori in solution and in the crystal, and the effects of these compounds on cell cultures of this bacterium
por: Narczyk, Marta, et al.
Publicado: (2022) -
Helicobacter pylori HP0377, a member of the Dsb family, is an untypical multifunctional CcmG that cooperates with dimeric thioldisulfide oxidase HP0231
por: Roszczenko, Paula, et al.
Publicado: (2015)